申请人:Senga Pharmaceutical Laboratory Inc.
公开号:US05811439A1
公开(公告)日:1998-09-22
A thiazolidinedione derivative represented by the following general formula (I): ##STR1## \x9bwherein the dotted line represents a single bond or a double bond, the thiazolidinedione ring residue is linked to either of 2-, 3-, 4-, 5- and 6-positions on the indole ring and R represents a group selected from the group consisting of hydrogen atom and alkyl, alkenyl, alkynyl, phenyl, aralkyl, heterocycloalkyl, arylsulfonyl and arylaminocarbonyl groups! or a pharmaceutically acceptable salt thereof exhibits excellent effects of reducing the blood sugar level and of reducing the lipid concentration in blood and is accordingly useful as a therapeutic agent for treating diabates mellitus. These derivatives and pharmaceutically acceptable salt thereof are almost free of any side effect.
以下是通用公式(I)所代表的噻唑烷二酮衍生物:##STR1## 其中虚线代表单键或双键,噻唑烷二酮环残基连接到吲哚环的2-、3-、4-、5-和6-位置中的任一位置,R代表从氢原子和烷基、烯基、炔基、苯基、芳基烷基、杂环烷基、芳基磺酰基和芳基氨基甲酰基组成的群中选择的一个群!或其药学上可接受的盐表现出降低血糖水平和降低血液中脂质浓度的优异效果,因此可用作治疗糖尿病的治疗剂。这些衍生物及其药学上可接受的盐几乎没有任何副作用。